Kristian Reich Biography and Net Worth

Kristian Reich is the Insider of MoonLake Immunotherapeutics. They are 60 years old.

What is Kristian Reich's net worth?: The estimated net worth of Kristian Reich is at least $1.15 million as of December 8th, 2025. Reich owns 72,908 shares of MoonLake Immunotherapeutics stock worth more than $1,151,217 as of February 12th. This net worth approximation does not reflect any other assets that Reich may own. Additionally, Reich receives an annual salary of $1,200,000.00 as Insider at MoonLake Immunotherapeutics. Learn More about Kristian Reich's net worth.
How old is Kristian Reich?: Reich is currently 58 years old. There are 2 older executives and no younger executives at MoonLake Immunotherapeutics. Learn More on Kristian Reich's age.
What is Kristian Reich's salary?: As the Insider of MoonLake Immunotherapeutics, Reich earns $1,200,000.00 per year. Learn More on Kristian Reich's salary.
How do I contact Kristian Reich?: The corporate mailing address for Reich and other MoonLake Immunotherapeutics executives is , , . MoonLake Immunotherapeutics can also be reached via phone at 41-41-510-8022 and via email at [email protected]. Learn More on Kristian Reich's contact information.
Has Kristian Reich been buying or selling shares of MoonLake Immunotherapeutics?: Kristian Reich has not been actively trading shares of MoonLake Immunotherapeutics within the last three months. Most recently, Kristian Reich sold 72,908 shares of the business's stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of $14.43, for a transaction totalling $1,052,062.44. Learn More on Kristian Reich's trading history.
Who are MoonLake Immunotherapeutics' active insiders?: MoonLake Immunotherapeutics' insider roster includes Matthias Bodenstedt (CFO), Kristian Reich (Insider), Silva Santos (CEO), and Simon Sturge (Director). Learn More on MoonLake Immunotherapeutics' active insiders.
Are insiders buying or selling shares of MoonLake Immunotherapeutics?: In the last twelve months, insiders at the sold shares 6 times. They sold a total of 6,902,886 shares worth more than $52,850,547.07. The most recent insider tranaction occured on December, 9th when CEO Da Silva Jorge Santos sold 70,000 shares worth more than $1,014,300.00. Insiders at MoonLake Immunotherapeutics own 12.0% of the company. Learn More about insider trades at MoonLake Immunotherapeutics.
Information on this page was last updated on 12/9/2025.

Kristian Reich Insider Trading History at MoonLake Immunotherapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2025	Sell	72,908	$14.43	$1,052,062.44
12/8/2025	Sell	130,000	$15.08	$1,960,400.00	72,908
2/27/2024	Sell	29,431	$55.00	$1,618,705.00	70,071
2/20/2024	Sell	10,000	$57.43	$574,300.00	100,071
2/16/2024	Sell	10,000	$60.15	$601,500.00	110,071
2/14/2024	Sell	10,000	$62.43	$624,300.00	130,071

Kristian Reich Buying and Selling Activity at MoonLake Immunotherapeutics

MoonLake Immunotherapeutics Company Overview

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

Today's Range

Now: $15.61

$15.27

$15.82

50 Day Range

MA: $14.89

$11.17

$18.49

2 Week Range

Now: $15.61

$5.95

$62.75

Volume

1,012,848 shs

Average Volume

2,844,039 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Kristian Reich Biography and Net Worth

What is Kristian Reich's net worth?

How old is Kristian Reich?

What is Kristian Reich's salary?

How do I contact Kristian Reich?

Has Kristian Reich been buying or selling shares of MoonLake Immunotherapeutics?

Who are MoonLake Immunotherapeutics' active insiders?

Are insiders buying or selling shares of MoonLake Immunotherapeutics?